Highbridge Capital Management’s Liminatus Pharma Warrants LIMNW Stock Holding History

Highbridge Capital Management’s Portfolio LIMNW Stock Details LIMNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Hold	0	–	–	–	283
2025 Q3	–	Hold	0	–	–	–	267
2025 Q2	–	Hold	0	–	–	–	245

Other funds holding LIMNW

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return